Laboratoire de Bioimagerie et Pathologies
UMR CNRS 7213


Partenaires

CNRS
Logo Universite de strasbourg
 

Rechercher

Sur ce site

Sur le Web du CNRS


Accueil du site > Equipe Signalisation tumorale et cibles thérapeutiques > Publications

Publication 2019

23 juillet 2019

M. COLLOT, E. BOUTANT, M. LEHMANN & A.S. KLYMCHENKO. BODIPY with tuned amphiphilicity as a fluorogenic plasma membrane probe. Bioconjug. Chem. 30, 192–199, 2019  IF 4.42  EQMELY‑EQDONT‑EQKLYM

E. CRUZ DA SILVA, M. DONTENWILL, L. CHOULIER & M. LEHMANN. Role of integrins in resistance to therapies targeting growth factor receptors in cancer (review). Cancers 11, E692, 2019 IF 5.33 – EQDONT

P. FECHTER, E. CRUZ DA SILVA, M.C. MERCIER, F. NOULET, N. ETIENNE-SELLOUM, D. GUENOT, M. LEHMANN, R. VAUCHELLES, S. MARTIN, I. LELONG-REBEL, A.M. RAY, C. SEGUIN, M. DONTENWILL & L. CHOULIER. RNA aptamers targeting integrin α5β1 as probes for cyto- and histofluorescence in glioblastoma. Mol. Ther.-Nucl. Acids 17, 63-77, 2019 IF 5.88 – EQDONT

N. GROYSBECK, A. STOESSEL, M. DONZEAU, E. CRUZ DA SILVA, M. LEHMANN, J.M. STRUB, S. CIANFERANI, K. DEMBELE & G. ZUBER. Synthesis and biological evaluation of 2.4 nm thiolate-protected gold nanoparticles conjugated to Cetuximab for targeting glioblastoma cancer cells via the EGFR. Nanotechnology 30, 184005, 2019 IF 3.47 – EQDONT